Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

08 mai 2017 07h00 HE | Source: MediWound Ltd.

MediWound Reports First Quarter 2017 Financial Results

YAVNE, Israel, May 08, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
03 mai 2017 07h00 HE | Source: MediWound Ltd.

MediWound Announces Successful GMP Manufacturing Audit by the Israeli Ministry of Health

YAVNE, Israel, May 03, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
01 mai 2017 07h00 HE | Source: MediWound Ltd.

MediWound to Host First Quarter 2017 Financial Results Conference Call on May 8, 2017 at 8:30 a.m. Eastern Time

YAVNE, Israel, May 01, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
30 mars 2017 08h59 HE | Source: MediWound Ltd.

MediWound’s NexoBrid® and EscharEx® to be Highlighted in Multiple Presentations at the Symposium on Advanced Wound Care Spring

YAVNE, Israel, March 30, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
17 mars 2017 13h21 HE | Source: MediWound Ltd.

MediWound Announces Conference Call and Webcast of “Meet the Experts” Panel Discussion Chaired by SunTrust Robinson Humphrey at the 49th American Burn Association Annual Meeting

YAVNE, Israel, March 17, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe...
14 mars 2017 07h00 HE | Source: MediWound Ltd.

MediWound’s NexoBrid® and EscharEx® to be Highlighted in Presentations at the American Burn Association 49th Annual Meeting

YAVNE, Israel, March 14, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
13 mars 2017 07h00 HE | Source: MediWound Ltd.

MediWound to Present at the Oppenheimer 27th Annual Healthcare Conference

YAVNE, Israel, March 13, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
03 mars 2017 07h00 HE | Source: MediWound Ltd.

Cost Analysis Demonstrating Significant Health Care Savings Utilizing NexoBrid® in Burn Management Published in BioMed Research International

YAVNE, Israel, March 03, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
21 févr. 2017 07h00 HE | Source: MediWound Ltd.

MediWound Reports 2016 Fourth Quarter and Full Year Financial Results

YAVNE, Israel, Feb. 21, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
14 févr. 2017 07h00 HE | Source: MediWound Ltd.

MediWound to Host 2016 Fourth Quarter and Full Year Financial Results Conference Call on February 21, 2017 at 8:30 a.m. Eastern Time

YAVNE, Israel, Feb. 14, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...

Page précédente

Page suivante